tiprankstipranks
Advertisement
Advertisement
Evolent Health downgraded to Hold from Buy at Truist
PremiumThe FlyEvolent Health downgraded to Hold from Buy at Truist
1M ago
Evolent Health: Near-Term Upside Seen as Limited; Hold Rating Reaffirmed with Unchanged $7 Price Target Amid Valuation and Policy Risks
Premium
Ratings
Evolent Health: Near-Term Upside Seen as Limited; Hold Rating Reaffirmed with Unchanged $7 Price Target Amid Valuation and Policy Risks
1M ago
Evolent Health Shareholders Approve Proposals at 2026 Meeting
Premium
Company Announcements
Evolent Health Shareholders Approve Proposals at 2026 Meeting
2M ago
Evolent Health appoints Archie Mayani as Chief Product Officer
PremiumThe FlyEvolent Health appoints Archie Mayani as Chief Product Officer
4M ago
Evolent Health price target lowered to $6 from $12 at Oppenheimer
Premium
The Fly
Evolent Health price target lowered to $6 from $12 at Oppenheimer
5M ago
Evolent Health: Conservative 2026 Guidance Masks Attractive Valuation and Upside to EBITDA Targets
Premium
Ratings
Evolent Health: Conservative 2026 Guidance Masks Attractive Valuation and Upside to EBITDA Targets
5M ago
Midday Fly By: Workday, Lowe’s in focus after earnings
PremiumThe FlyMidday Fly By: Workday, Lowe’s in focus after earnings
5M ago
Balancing Near-Term Execution Risk With Long-Term EBITDA Upside: Why Evolent Remains a Buy Despite a Lowered Target
Premium
Ratings
Balancing Near-Term Execution Risk With Long-Term EBITDA Upside: Why Evolent Remains a Buy Despite a Lowered Target
5M ago
Evolent Health price target lowered to $8 from $10 at BTIG
Premium
The Fly
Evolent Health price target lowered to $8 from $10 at BTIG
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100